{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:03:40Z","timestamp":1774494220451,"version":"3.50.1"},"reference-count":63,"publisher":"Impact Journals, LLC","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2021,7,20]]},"DOI":"10.18632\/oncotarget.28011","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:47:19Z","timestamp":1625143639000},"page":"1470-1489","source":"Crossref","is-referenced-by-count":22,"title":["Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K\/Akt\/mTOR survival pathway and inducing apoptosis"],"prefix":"10.18632","volume":"12","author":[{"given":"Reza Bayat","family":"Mokhtari","sequence":"first","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Experimental Therapeutics, Thoreau Laboratory for Global Health, M2D2, University of Massachusetts, Lowell, MA, USA"},{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bessi","family":"Qorri","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Baluch","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergy, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Sparaneo","sequence":"additional","affiliation":[{"name":"Laboratory of Oncology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico Pio","family":"Fabrizio","sequence":"additional","affiliation":[{"name":"Laboratory of Oncology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia Anna","family":"Muscarella","sequence":"additional","affiliation":[{"name":"Laboratory of Oncology, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albina","family":"Tyker","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine University of Chicago, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Q.P.S. Holdings LLC, Pencader Corporate Center, Newark, DE, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ling Margaret","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Engineering, The Edward S. Rogers Sr. Department of Electrical & Computer Engineering, University of Toronto, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron R.","family":"Szewczuk","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikul","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, Thoreau Laboratory for Global Health, M2D2, University of Massachusetts, Lowell, MA, USA"},{"name":"Department of Cancer and Stem Cell Biology, KaviKrishna Laboratory, Guwahati Biotech Park, Indian Institute of Technology, Guwahati, Assam, India"},{"name":"Department of Immunology and Infectious Diseases, Forsyth Institute, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Yeger","sequence":"additional","affiliation":[{"name":"Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1534735404270757","article-title":"Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy","volume":"3","author":"McCarty","year":"2004","journal-title":"Integr Cancer Ther"},{"key":"2","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"6","author":"Harris","year":"2004","journal-title":"Cancer Res"},{"key":"3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/1471-2407-13-378","article-title":"Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines","volume":"1","author":"Yeger","year":"2013","journal-title":"BMC Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11523-015-0386-5","article-title":"Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN)","volume":"1","author":"Farhat","year":"2016","journal-title":"Target Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1158\/2159-8290.CD-16-0716","article-title":"Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy","volume":"6","author":"Vanhaesebroeck","year":"2016","journal-title":"Cancer Discov"},{"key":"6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1530\/ERC-13-0042","article-title":"mTOR, p70S6K, AKT, and ERK1\/2 levels predict sensitivity to mTOR and PI3K\/mTOR inhibitors in human bronchial carcinoids","volume":"2","author":"Zatelli","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fendo.2015.00188","article-title":"The PI3K\/Akt Pathway in Tumors of Endocrine Tissues","volume":"6","author":"Hague","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/1471-2407-10-269","article-title":"Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells","volume":"1","author":"Xu","year":"2010","journal-title":"BMC Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbcan.2014.08.003","article-title":"Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms","volume":"184","author":"Srivastava","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3892\/ijo.2016.3621","article-title":"Dexamethasone downregulates expression of carbonic anhydrase IX via HIF-1\u03b1 and NF-\u03baB-dependent mechanisms","volume":"4","author":"Pastorek","year":"2016","journal-title":"Int J Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1677\/ERC-09-0085","article-title":"Hypoxia stimulates CXCR4 signalling in ileal carcinoids","volume":"1","author":"Nilsson","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"19413","DOI":"10.18632\/oncotarget.4989","article-title":"Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition","volume":"6","author":"Harris","year":"2015","journal-title":"Oncotarget"},{"key":"13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/stem.1142","article-title":"HIF-2\u03b1 suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells","volume":"3","author":"Yeger","year":"2012","journal-title":"Stem Cells"},{"key":"14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1186\/s12885-019-6018-1","article-title":"Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane","volume":"1","author":"Yeger","year":"2019","journal-title":"BMC Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cbpa.2015.02.005","article-title":"Targeting carbonic anhydrase IX with small organic ligands","volume":"2","author":"Krall","year":"2015","journal-title":"Curr Opin Chem Biol"},{"key":"16","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1101\/gad.225680.113","article-title":"The emerging role of the Nrf2-Keap1 signaling pathway in cancer","volume":"2","author":"Zhang","year":"2013","journal-title":"Genes Dev"},{"key":"17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1042\/BST20150048","article-title":"Dysregulation of the Keap1-Nrf2 pathway in cancer","volume":"4","author":"Levonen","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"18","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.ejca.2005.05.008","article-title":"Inhibition of survival signalling by dietary polyphenols and indole-3-carbinol","volume":"4","author":"Manson","year":"2005","journal-title":"Eur J Cancer"},{"key":"19","unstructured":"Howlader, Noone, Krapcho, Miller, Brest, Yu, Ruhl, Tatalovich, Mariotto, Lewis, Chen, Feuer, Cronin (eds). SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2017\/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020."},{"key":"20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.20517\/2394-4722.2017.18","article-title":"A new twist to neurotransmitter receptors and cancer","volume":"3","author":"Schuller","year":"2017","journal-title":"J Cancer Metastasis Treat"},{"key":"21","doi-asserted-by":"publisher","first-page":"586757","DOI":"10.3389\/fcell.2020.586757","article-title":"Systemic Regulation of Cancer Development by Neuro-Endocrine-Immune Signaling Network at Multiple Levels","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"22","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2174\/0929867043365323","article-title":"Oxidative stress and cell signalling","volume":"1","author":"Chiarpotto","year":"2004","journal-title":"Curr Med Chem"},{"key":"23","first-page":"9","article-title":"Nutrigenomics and cancer","volume":"1","author":"Jabbari","year":"2009","journal-title":"Avicenna J Med Biotechnol"},{"key":"24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tips.2005.04.004","article-title":"Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects","volume":"2","author":"Kong","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1464-410X.2005.05944.x","article-title":"Targeting apoptosis in prostate cancer: focus on caspases and inhibitors of apoptosis proteins","volume":"9","author":"Fitzpatrick","year":"2005","journal-title":"BJU Int"},{"key":"26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12885-017-3126-7","article-title":"Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma","volume":"1","author":"Yeger","year":"2017","journal-title":"BMC Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1158\/1535-7163.MCT-12-0995","article-title":"BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer","volume":"1","author":"Brekken","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.canlet.2004.09.042","article-title":"Nrf2 as a novel molecular target for chemoprevention","volume":"22","author":"Surh","year":"2005","journal-title":"Cancer Lett"},{"key":"29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tifs.2017.02.002","article-title":"KEAP1 and Done? Targeting the NRF2 Pathway with Sulforaphane","volume":"6","author":"Kensler","year":"2017","journal-title":"Trends Food Sci Technol"},{"key":"30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/B978-0-12-398339-8.00002-1","article-title":"The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?","volume":"6","author":"Copple","year":"2012","journal-title":"Adv Pharmacol"},{"key":"31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1-NRF2 System in Cancer","volume":"7","author":"Yamamoto","year":"2017","journal-title":"Front Oncol"},{"key":"32","doi-asserted-by":"publisher","first-page":"2492063","DOI":"10.1155\/2018\/2492063","article-title":"Epigenetic versus Genetic Deregulation of the KEAP1\/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs","volume":"201","author":"Muscarella","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"33","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3390\/ijms20102531","article-title":"Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors","volume":"2","author":"Balsamo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13148-015-0132-y","article-title":"Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon","volume":"7","author":"Dashwood","year":"2015","journal-title":"Clin Epigenetics"},{"key":"35","doi-asserted-by":"publisher","first-page":"61403","DOI":"10.18632\/oncotarget.8968","article-title":"Sulforaphane-induced apoptosis involves the type 1 IP3 receptor","volume":"7","author":"Kopacek","year":"2016","journal-title":"Oncotarget"},{"key":"36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-016-0311-0","article-title":"Modification of platinum sensitivity by KEAP1\/NRF2 signals in non-small cell lung cancer","volume":"9","author":"Chen","year":"2016","journal-title":"J Hematol Oncol"},{"key":"37","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1158\/1535-7163.MCT-09-0589","article-title":"Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth","volume":"9","author":"Biswal","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"38","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1371\/journal.pmed.0030420","article-title":"Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer","volume":"3","author":"Biswal","year":"2006","journal-title":"PLoS Med"},{"key":"39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/pho.2016.4151","article-title":"Salidroside\u2019s Protection Against UVB-Mediated Oxidative Damage and Apoptosis Is Associated with the Upregulation of Nrf2 Expression","volume":"3","author":"Guo","year":"2017","journal-title":"Photomed Laser Surg"},{"key":"40","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Yeger","year":"2017","journal-title":"Oncotarget"},{"key":"41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12079-017-0401-y","article-title":"The role of Sulforaphane in cancer chemoprevention and health benefits: a mini-review","volume":"1","author":"Yeger","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2012.06.007","article-title":"Keap1: one stone kills three birds Nrf2, IKK\u03b2 and Bcl-2\/Bcl-xL","volume":"32","author":"Zheng","year":"2012","journal-title":"Cancer Lett"},{"key":"43","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/ptr.3397","article-title":"Sulforaphane inhibits oral carcinoma cell migration and invasion","volume":"2","author":"Youn","year":"2011","journal-title":"Phytother Res"},{"key":"44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.biochi.2019.08.003","article-title":"Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process","volume":"16","author":"Soukhtanloo","year":"2019","journal-title":"Biochimie"},{"key":"45","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1200\/JCO.2014.59.0018","article-title":"Inhibition of the PI3K\/AKT\/mTOR Pathway in Solid Tumors","volume":"3","author":"LoRusso","year":"2016","journal-title":"J Clin Oncol"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy","author":"Bishayee","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"2","author":"Manning","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"48","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.3390\/ijms14048213","article-title":"The importance of the PI3K\/AKT\/MTOR pathway in the progression of ovarian cancer","volume":"1","author":"Landen","year":"2013","journal-title":"Int J Mol Sci"},{"key":"49","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/jcb.25729","article-title":"Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K\/AKT and MAPK Signaling Pathways","volume":"11","author":"Song","year":"2017","journal-title":"J Cell Biochem"},{"key":"50","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/mto.2016.18","article-title":"Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K\/Akt\/mTOR signaling pathways in lung cancer","volume":"3","author":"Chen","year":"2016","journal-title":"Mol Ther Oncolytics"},{"key":"51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/ijms19030747","article-title":"The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?","volume":"1","author":"Campana","year":"2018","journal-title":"Int J Mol Sci"},{"key":"52","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC)","volume":"1","author":"Tan","year":"2020","journal-title":"Thorac Cancer"},{"key":"53","doi-asserted-by":"publisher","first-page":"153062","DOI":"10.1016\/j.phymed.2019.153062","article-title":"The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner","volume":"8","author":"Dinkova-Kostova","year":"2021","journal-title":"Phytomedicine"},{"key":"54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/14756366.2016.1217854","article-title":"Selective inhibition of human carbonic anhydrase IX in Xenopus oocytes and MDA-MB-231 breast cancer cells","volume":"3","author":"Matulis","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"55","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.2174\/138161210793429832","article-title":"Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain","volume":"1","author":"Pastorekova","year":"2010","journal-title":"Curr Pharm Des"},{"key":"56","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1074\/jbc.M111.286062","article-title":"Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain","volume":"28","author":"Pastorekova","year":"2012","journal-title":"J Biol Chem"},{"key":"57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/onc.2016.184","article-title":"The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer","volume":"3","author":"Ebner","year":"2017","journal-title":"Oncogene"},{"key":"58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcell.2016.00027","article-title":"Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction","volume":"4","author":"Dedhar","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1165\/rcmb.2014-0054OC","article-title":"Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors","volume":"5","author":"Yeger","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"60","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1158\/0008-5472.CAN-07-6171","article-title":"Serotonin receptors, novel targets of sulforaphane identified by proteomic analysis in Caco-2 cells","volume":"6","author":"Bao","year":"2008","journal-title":"Cancer Res"},{"key":"61","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1158\/1078-0432.CCR-07-0009","article-title":"Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy","volume":"1","author":"Havelka","year":"2007","journal-title":"Clin Cancer Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-3-319-18440-1_35","article-title":"Augmented 5-HT Secretion in Pulmonary Neuroepithelial Bodies from PHD1 Null Mice","volume":"86","author":"Cutz","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4161\/epi.6.3.14408","article-title":"Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient\u2019s outcome","volume":"6","author":"Valori","year":"2011","journal-title":"Epigenetics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T15:23:58Z","timestamp":1626794638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":63,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2021,7,20]]}},"alternative-id":["28011"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28011","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}